No Data
No Data
No Data
No Data
No Data
Core One Labs Signs Initial Agreement for Potential Sale of Proprietary Biosynthetic Psilocybin
Seeking AlphaDec 11, 2023 17:21
Core One Labs Inc. Announces Initial Agreement for Potential Sale of Proprietary Biosynthetic Psilocybin, Facilitating Entry Into the International Market
VANCOUVER, BC / ACCESSWIRE / December 8, 2023 / Core One Labs Inc. (CSE:COOL)(OTCQB:CLABF)(Frankfurt:LD6) (WKN:A3CSSU) (the "Company" or "Core One") is pleased to announce the signing of an Initial Ag
AccesswireDec 9, 2023 07:55
Core One Labs' Akome Reveals Impressive Results for Its Psychedelic Bio-Compounds Designed to Target Alzheimer's and Parkinson's, Showing Potential to Outperform Current Treatment Methods
VANCOUVER, BC / ACCESSWIRE / December 1, 2023 / Core One Labs Inc. ("Core One" or the "Company") (CNSX:COOL)(OTCQB:CLABF)(Frankfurt:LD6) (WKN: A3CSSU), an emerging leader in the field of neuroscience
AccesswireDec 2, 2023 08:00
Core One's Akome Reveals Groundbreaking Positive Results From Its Second Round of Stage 1 Animal Model Studies for Bio-Compounds Targeting Alzheimer's and Parkinson's Disease
VANCOUVER, BC / ACCESSWIRE / August 4, 2023 / Core One Labs Inc. (CSE:COOL) (OTCQB:CLABF) (Frankfurt:LD6, WKN:A3CSSU), (the "Company" or "Core One") is delighted to announce the receipt of additional
AccesswireAug 5, 2023 07:25
Core One Labs', Awakened Biosciences, Announces Groundbreaking Step Forward in Isolating and Purifying Psilocybin From Mushroom Biomass
Core One's Wholly-Owned Subsidiary has filed a patent application with the United States Patent and Trademark OfficeVANCOUVER, BC / ACCESSWIRE / August 1, 2023 / Core One Labs Inc. (CSE:COOL)(OTCQB:CL
AccesswireAug 2, 2023 07:55
Core One's Akome Receives Positive Preliminary Stage 1 Animal Model Study Results for Bio-Compound Targeting Alzheimer's and Parkinson's Disease
VANCOUVER, BC / ACCESSWIRE / July 28, 2023 / Core One Labs Inc. (CSE:COOL)(OTCQB:CLABF)(Frankfurt:LD6) (WKN:A3CSSU) (the "Company" or "Core One"), is excited to share positive results from its first r
AccesswireJul 29, 2023 07:25
No Data
No Data